22nd Century Group Inc (USD)
XXII
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.66 | 0.72
52-Wk Range |
Last Close0.68
Mkt Cap (m)94.42
Dividend yield-
ISINUS90137F1030
Volume852,223
Exchange VenueASE

Company Profile

22nd Century Group Inc is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.

Key Information
Price/Earning-
Price/Book1.52
Price/Sales3.31
P/CF-
Rev Growth (3 year avg)28.13
EPS Growth (3 year avg)-
Operating Margin % -86.81
Net Margin %-102.81
Return on Equity-39.84
Debt/Equity0.02

Documents

Prospectus
en 23/12/2019
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)1912172626
Operating Income (m)-12-12-11-13-24-22
Net Income (m)-16-11-12-13-8-27
Basic EPS-0.26-0.16-0.15-0.13-0.06-0.21
Avg. Diluted Shares Outstanding (m)606880101124126
Balance Sheet
USD201420152016201720182019
Current Assets (m)11717686143
Non Current Assets (m)111111121626
Total Assets (m)221828807769
Current Liabilities (m)333456
Total Liabilities (m)------
Total Equity (m)151224757162
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-7-7-10-12-18-15
Capital Expenditure (m)-2-1-2-1-1
Figures are quoted in USD unless stated otherwise
-
No change
$
0.68
Last Price